PainSci notes on Farrell 2023:
This UK study went mining for data about hundreds of thousands of patients, identifying a strong link between pain and a major inflammatory biomarker (CRP) compared to people without pain… and that link was strong even when a great variety of other common correlates with pain were factored out (like income, demographics, mental health). In other words, inflammation is there along with pain regardless of other factors, which the authors reckon means there is "a possible independent biological mechanism" for pain. Inflammation and pain may occur more in certain kinds of people, but not because of who they are — because the link between pain and inflammation is there in everyone. Who people are is clearly relevant to chronic pain, but this data suggests that it’s not the whole story.
original abstract †Abstracts here may not perfectly match originals, for a variety of technical and practical reasons. Some abstacts are truncated for my purposes here, if they are particularly long-winded and unhelpful. I occasionally add clarifying notes. And I make some minor corrections.
Inflammation is linked with chronic pain but the extent to which this relationship is associated with biopsychosocial factors is not known. We investigated relationships between blood C-reactive protein (CRP) and regional chronic pain conditions adjusting for a large range and number of potential confounders. We performed cross-sectional analyses using the UK Biobank (N=415,567) comparing CRP in people reporting any of nine types of regional chronic pain with pain-free controls. Using logistic regression modelling, we explored relationships between CRP and the presence of chronic pain, with demographic, socioeconomic, psychological/lifestyle factors, and medical comorbidities as covariates. CRP was higher in chronic pain at any site compared with controls (Females: median [IQR] 1.60mg/L [2.74] vs 1.17mg/L [1.87], P<0.001; Males: 1.44mg/L [2.12] vs 1.15mg/L [1.65], P<0.001). In males, associations between CRP and all types of chronic pain were attenuated but remained significant after adjustment for biopsychosocial covariates (OR range 1.08 to 1.49, P≤0.001). For females, adjusted associations between CRP and pain remained significant for most chronic pain types (OR range 1.07 to 1.34, P<0.001) except for facial pain (OR 1.04, P=0.17) and headache (OR 1.02, P=0.07)-although these non-significant findings may reflect reduced sample size. The significant association between CRP and chronic pain after adjustment for key biopsychosocial confounders implicates an independent underlying biological mechanism of inflammation in chronic pain. The presence of yet unknown or unmeasured confounding factors cannot be ruled out. Our findings may inform better targeted treatments for chronic pain.
PERSPECTIVE: Using a large-scale dataset, this article investigates associations between chronic pain conditions and blood C-reactive protein (CRP), to evaluate the confounding effects of a range of biopsychosocial factors. CRP levels were higher in those with chronic pain vs controls after adjusting for confounders-suggesting a possible independent biological mechanism.
This page is part of the PainScience BIBLIOGRAPHY, which contains plain language summaries of thousands of scientific papers & others sources. It’s like a highly specialized blog. A few highlights:
- Cannabidiol (CBD) products for pain: ineffective, expensive, and with potential harms. Moore 2023 J Pain.
- Inciting events associated with lumbar disc herniation. Suri 2010 Spine J.
- Prediction of an extruded fragment in lumbar disc patients from clinical presentations. Pople 1994 Spine (Phila Pa 1976).
- Characteristics of patients with low back and leg pain seeking treatment in primary care: baseline results from the ATLAS cohort study. Konstantinou 2015 BMC Musculoskelet Disord.
- Effectiveness and cost-effectiveness of universal school-based mindfulness training compared with normal school provision in reducing risk of mental health problems and promoting well-being in adolescence: the MYRIAD cluster randomised controlled trial. Kuyken 2022 Evid Based Ment Health.